...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [~3H] Dopamine Overflow form Superfused Rat Striatal Slices
【24h】

N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [~3H] Dopamine Overflow form Superfused Rat Striatal Slices

机译:N-n-烷基吡啶类似物,一类新型的烟碱受体拮抗剂:选择性抑制尼古丁诱发的[〜3H]多巴胺从熔融大鼠纹状体切片中溢出。

获取原文
获取原文并翻译 | 示例
           

摘要

Structural simplification of N-n-alkylnicotinium analogs, antagonists at neuronal nicotinic acetylcholine receptors (nAChRs), was achieved by removal of the N-methylpyrrolidion moiety affording N-n-alkylpyridinium analogs with carbon chain lengths of C1 to C20. N-n-Alkylpyridinium analog inhibitio of [~3H] nicotine and [~3H] methyllycaconitine binding to rat brain membranes assessed interaction with alpha 4 beta2* and alpha 7* nAChRs, respectively, whereas ihhibition of nicotine-evoked ~3H overflow from [~3H]dopamine ([~3H]DA)-preloaded rat triatal slices assessed antagonist action at nAChR subtypes mediating nicotine-evoked DA release. No inhibition of [~3H]methyllycaconitine binding was observed, although N-n-alkylpyridinium analogs had low affinity for [~3H] nicotine binding sites, i.e., 1 to 3 orders of magnitude lower than that of the respective N-n-alkylnico-tinium analogs. These results indicate that the N-methylpyrrolidino moiety in the N-n-alkylnicotinium analogs is a structural requirement for potent inhibition of alpha 4 beta 2* nAChRs. Inportantly N-n-alkylpyridinium analogs with n-alkyl chains
机译:N-n-烷基烟碱类似物(神经元烟碱乙酰胆碱受体(nAChRs)的拮抗剂)的结构简化是通过除去提供碳链长度为C1至C20的N-n-烷基吡啶鎓类似物的N-甲基吡咯烷酮部分实现的。 Nn-烷基吡啶类似物对[〜3H]尼古丁和[〜3H]甲基甘可碱碱与大鼠脑膜结合的抑制作用分别评估了与α4 beta2 *和α7* nAChR的相互作用,而抑制烟碱诱发的〜3H从[〜3H预先装载]多巴胺([〜3H] DA)的大鼠三体切片评估了介导尼古丁引起的DA释放的nAChR亚型的拮抗剂作用。尽管N-n-烷基吡啶鎓类似物对[〜3H]烟碱结合位点具有低亲和力,即比各自的N-n-烷基烟酸-锡类似物低1-3个数量级,但未观察到对[〜3H]甲基lycaconitine结合的抑制。这些结果表明,N-n-烷基烟碱类似物中的N-甲基吡咯烷酮部分是有效抑制α4β2* nAChRs的结构要求。具有正烷基链

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号